EQL Pharma's (STO:EQL) Earnings Are Of Questionable Quality
May 16
EQL Share Price Performance
SEK 84.20
30.80 (57.68%)
6.4% undervalued intrinsic discount
SEK 90.00
Fair Value
Price SEK 84.20
AnalystConsensusTarget SEK 90.00
Mandelman SEK 86.37
Fair ValueSEK 90.00
Share PriceSEK 84.20
6.4% undervalued intrinsic discount
EQL Community Narratives
AN
Fair Value SEK 90.00 6.4% undervalued intrinsic discount
European Market Expansion And Pipeline Development Will Unlock Potential
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
MA
Fair Value SEK 86.37 2.5% undervalued intrinsic discount
EQL Pharma's management aiming for 30% Revenue Growth in 5 Years
1users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
EQL Pharma AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 05, 2025
- Earnings per share (EPS)
- 1.46
- Gross Margin
- 41.49%
- Net Profit Margin
- 10.69%
- Debt/Equity Ratio
- 195.7%
EQL Pharma AB (publ) Competitors
Snowflake Analysis
About EQL
- Founded
- 2006
- Employees
- 20
- CEO
- WebsiteView website
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
Market Insight
The number of IPOs and the capital raised this year are on track to outpace the last three years combined. And the thing is, successful IPOs attract more IPOs. Some will be genuine gems, while others, not so much. That’s why this week, we’re digging into the IPO market, and more importantly, how you can improve your odds of spotting a winner.
Continue reading
Swedish Market Performance
- 7 Days: -1.8%
- 3 Months: 3.4%
- 1 Year: -2.7%
- Year to Date: 0.9%
Over the last 7 days, the market has dropped 1.8%, driven by pullbacks in the Financials and Industrials sectors of 2.4% and 1.4%, respectively. On the other hand, the Energy has risen by 7.0%. In the last 12 months the market has been flat overall. Earnings are forecast to grow by 17% annually. Market details ›